Nick C. Patel, PharmD, PhD

Articles by Nick C. Patel, PharmD, PhD

Relationship of Diabetes Complications Severity to Healthcare Utilization and Costs Among Medicare Advantage Beneficiaries

ByLeslie Hazel-Fernandez, PhD, MPH,Yong Li, PhD,Damion Nero, PhD,Chad Moretz, ScD,S. Lane Slabaugh, PharmD, MBA,Yunus Meah, PharmD,Jean Baltz, MMSc, MSW,Nick C. Patel, PharmD, PhD,Jonathan R. Bouchard, MS, RPh

February 13th 2015

This retrospective cohort study in a Medicare Advantage population posits that type 2 diabetes mellitus complications pose an excess burden on healthcare resource use and related costs.

Latest Updated Articles

Relationship of Diabetes Complications Severity to Healthcare Utilization and Costs Among Medicare Advantage Beneficiaries
Published: February 13th 2015 | Updated:

Nick C. Patel, PharmD, PhD

Articles by Nick C. Patel, PharmD, PhD

Relationship of Diabetes Complications Severity to Healthcare Utilization and Costs Among Medicare Advantage Beneficiaries

Latest Updated Articles

Trending on AJMC

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

Guidelines for Bronchiectasis Highlight Multiple Treatment Methods

Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits

Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD